Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications
about
FAAH inhibitors in the limelight, but regrettablyThe endocannabinoid system as a potential therapeutic target for pain modulationEffect of the synthetic cannabinoid HU-210 on quorum sensing and on the production of quorum sensing-mediated virulence factors by Vibrio harveyi.Comparisons of Δ9-Tetrahydrocannabinol and Anandamide on a Battery of Cognition-Related Behavior in Nonhuman PrimatesSelf-administration of the anandamide transport inhibitor AM404 by squirrel monkeysEffects of fatty acid amide hydrolase (FAAH) inhibitors on working memory in rats.Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex Slices.Mustard vesicants alter expression of the endocannabinoid system in mouse skin.No more pain upon Gq-protein-coupled receptor activation: role of endocannabinoids.Cannabinoid signaling in health and disease.Cannabinoid Receptor Signaling in Central Regulation of Feeding Behavior: A Mini-Review.Endocannabinoids exert CB1 receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 Tat protein.Targeting the endogenous cannabinoid system to treat neuropathic pain.Inhibition of FAAH confers increased stem cell migration via PPARαRare genetic variants in the endocannabinoid system genes CNR1 and DAGLA are associated with neurological phenotypes in humans.Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor.Early phytocannabinoid chemistry to endocannabinoids and beyond.Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses.The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2.Maternal separation and early stress cause long-lasting effects on dopaminergic and endocannabinergic systems and alters dendritic morphology in the nucleus accumbens and frontal cortex in rats.Fatty Acid Amide Hydrolase Inhibition by JNJ-42165279: A Multiple-Ascending Dose and a Positron Emission Tomography Study in Healthy Volunteers.
P2860
Q28067151-D0E4CF70-A0C3-4365-98E6-B0D54229D8F0Q28247621-D3FF0B73-106D-462E-9ECB-248B6BD34F2DQ35743021-8AE01C23-9655-4C49-82F3-6537FA726A71Q36733510-D9B96DE4-0027-45A7-8230-7CD7EDEFC952Q36839896-1124ADDD-F9E7-414B-82C3-840C4F77AE5DQ36840135-97429D8E-DDE7-485C-A666-3D2A9C512DF8Q36844731-044EFDE5-1813-474F-AC4F-1CCDF3AA941EQ37099962-51956805-21F5-4E57-94D3-968A8610709FQ38185075-F1C7A82C-4A07-4007-BC24-E44EF6790B75Q39163671-D9BF2B07-A6AE-4D1F-9072-4C45229E7095Q39360870-BBE76BDF-F094-4C94-B160-F6348E11CA57Q40112882-42E1AE3D-2E48-44F7-9A65-8345932AD57BQ41990169-EA9829DD-4858-4E29-820B-E77FF20BB0E4Q42262304-0EC82F8E-7EBC-429F-AF89-12115BC652CEQ47141476-F4DC2D30-D0F9-48CC-B276-12503EEA34D0Q47593740-C44E0E99-A142-4A1C-9755-B6116EE68A05Q48062717-37788E0C-42FA-4F19-BC43-E2F678863D9CQ48369538-96DE8B00-4191-48B2-BF8F-2099C1DE69AFQ50142905-CF937E9D-6A0B-4C5F-8156-7E7200A7EA3DQ52147129-8B509080-B49E-47FE-9D3F-3432414CD6AAQ52633440-6D656627-D762-4480-9BDD-47E96AD73A85
P2860
Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Elevating endocannabinoid leve ...... ntial therapeutic applications
@ast
Elevating endocannabinoid leve ...... ntial therapeutic applications
@en
Elevating endocannabinoid leve ...... ntial therapeutic applications
@nl
type
label
Elevating endocannabinoid leve ...... ntial therapeutic applications
@ast
Elevating endocannabinoid leve ...... ntial therapeutic applications
@en
Elevating endocannabinoid leve ...... ntial therapeutic applications
@nl
prefLabel
Elevating endocannabinoid leve ...... ntial therapeutic applications
@ast
Elevating endocannabinoid leve ...... ntial therapeutic applications
@en
Elevating endocannabinoid leve ...... ntial therapeutic applications
@nl
P2860
P3181
P1476
Elevating endocannabinoid leve ...... ntial therapeutic applications
@en
P2093
Roger G Pertwee
P2860
P304
P3181
P356
10.1017/S0029665113003649
P407
P577
2013-10-18T00:00:00Z